Prevalence, Profile and Treatment Outcome of Tuberculosis-Human Immunodeficiency Virus Co-Infection in South Eastern Nigeria: A 3-Year Retrospective Study
Main Article Content
Keywords
Tuberculosis, HIV, Co-Infection, Nigeria
Abstract
Background: Tuberculosis (TB) and the Human Immune Deficiency Virus (HIV) represent major public health challenges and are intricately linked to each other. This is more prevalent in the sub-Saharan African region, where about 80% of this co-infection is recorded. This study aimed to review the prevalence, profile, and treatment outcome of TB-HIV co-infected patients.
Methodology: A hospital-based retrospective study was conducted in a tertiary center in southeast Nigeria for the period 2015–2017. Information elicited from participant’s medical records included socio-demographic profile (age, sex, residential area, and occupation), Cluster of Differentiation 4 (CD4) count level at the time of diagnosis of co-infection, weight, treatment outcome, as well as the record of the number of TB patients who presented within this same period.
Results: The total number of TB/HIV co-infected patients who participated in the study during this period was 207, with a prevalence of TB/HIV co-infection of 33.9%. The highest proportion of cases was recorded among participants within the age group of 31–40, and the cases of co-infection were more common in males (58.9%) and students (27.5%). The results also showed a significant relationship between gender, occupation, residential area, and TB/HIV co-infection. Most of the co-infected participants had a CD4 count of <300 cells/mm3 and an associated poor treatment outcome of 41.1%.
Conclusions: TB/HIV co-infection needs to be properly addressed, and screening for HIV among TB patients should be a priority. This will help in early diagnosis and subsequently improve the treatment outcome of both diseases.
References
2. WHO. Global HIV & AIDS statistics — Fact sheet | UNAIDS [Internet]. [cited 2023 Jul 17]. Available from: https://www.unaids.org/en/resources/fact-sheet
3. Nissapatorn V, Lee C, Ithoi I, Yik FM, Abdullah KA. Tuberculosis in AIDS patients. Malays J Med Sci. 2003;10(1):60-4.
4. Sabine MH, Barbara C, Catherine K, Peter M, Joep MA, Andy IMH et al, integration of HIV and TB services results in improved TB treatment outcomes and earlier, prioritized ART initiation in a large urban HIV clinic in Uganda. -J Acquir Immune Defic Syndr. 2012;60(2):e29-35.
5. Lumu I, Musaazi J, Semeere A, Handel I, Castelnuovo B. et al. Survival and predictors of mortality after completion of TB treatment among people living with HIV: a 5-year analytical cohort. BMC Infect Dis 2023;23, 238.https://doi.org/10.1186/s12879-023-08217-9
6. Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Tuberculosis and HIV Co-Infection. PLoS Pathog 2021;8(2): e1002464. https://doi.org/10.1371/journal.ppat.1002464
7. Tesfaye B, Alebel A, Gebrie A, Zegeye A, Tesema C, Kassie B. The twin epidemics: Prevalence of TB/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis. PLoS One. 2018;13(10):e0203986. doi: 10.1371/journal.pone.0203986.
8. Seung KJ, Keshavjee S, Rich ML. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):017863. doi: 10.1101/cshperspect.a017863. PMID: 25918181; PMCID: PMC4561400
9. Adejumo OA, Daniel OJ, Otesanya AF, Adegbola AA, Femi-Adebayo T, Bowale A, et al. Factors associated with HIV/TB co-infection among drug-sensitive tuberculosis patients managed in a secondary health facility in Lagos, Nigeria. Afr J Infect Dis. 2017 Jun 8;11(2):75–82.
10. Reuben R, Gyar s. D, Dauda E. Prevalence of Tuberculosis in HIV/AIDS Patients in Lafia, Central Nigeria. International Journal of Current Microbiology and Applied Sciences. 2014;27;3:831–8.
11 Reward EE, Ike AC, Muo SO, Soga-Oke BF, Mbaawuaga EM. Coinfection of Tuberculosis and HIV in Nigeria: A Systematic Review and Meta-analysis. AIDS Rev. 2020;23(2):82-90. doi: 10.24875/AIDSRev.20000068.
12. Ugwu KO, Agbo MC, Ezeonu IM. prevalence of tuberculosis, drug-resistant tuberculosis, and HIV/TB co-infection in Enugu, Nigeria. Afr J Infect Dis. 2021;15(2):24–30.
13. Tadesse S. HIV co-infection among tuberculosis patients in Dabat, Northwest Ethiopia. J Infect Dis Immun. 2013;5(3):29–32.
14. Nwosu IA, Ekpechu J, Njemanze VC, Ukah J, Eyisi E, Ohuruogu B, et al. Self-Report on Men’s Beliefs and Perceptions on Their Alcohol Use/Misuse in Southeast Nigeria. Am J Mens Health. 2022;16(6):15579883221130193.
15. Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV Coinfection. Cold Spring Harb Perspect Med. 2015;5(7):a017871. doi: 10.1101/cshperspect.a017871.
6. Mekonnen D, Derbie A, Desalegn E. TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study. BMC Res Notes. 2015;8:666.
17. Belay M, Bjune G, Abebe F. Prevalence of tuberculosis, HIV, and TB-HIV co-infection among pulmonary tuberculosis suspects in a predominantly pastoralist area, northeast Ethiopia. Glob Health Action. 2015;8:10.3402/gha.v8.27949.
18. Tancredi MV, Sakabe S, Waldman EA. Mortality and survival of tuberculosis coinfected patients living with AIDS in São Paulo, Brazil: a 12-year cohort study. BMC Infect Dis. 2022;22:223.
19. Patel AK, Thakrar SJ, Ghanchi FD. Clinical and laboratory profile of patients with TB/HIV coinfection: A case series of 50 patients. Lung India. 2011;28(2):93–6.
20. Hoffmann CJ, Schomaker M, Fox MP, Mutevedzi P, Giddy J, Prozesky H, Wood R, Garone DB, Egger M, Boulle A; IeDEA Southern Africa Collaboration. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa. J Acquir Immune Defic Syndr. 2013;63(1):34-41. doi: 10.1097/QAI.0b013e318287c1fe.
21. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania. BMC Public Health. 2008;8(1):341.
22. Kesari SP, Basnett B, Chettri A. et al Spectrum of Tuberculous Infection in Patients Suffering from HIV/AIDS and Its Correlation with CD-4 Counts: A Retrospective Study from Sikkim. Indian J Otolaryngol Head Neck Surg. 2019;71(2):167–71.
23. Agbor AA, Bigna JJR, Plottel CS, Billong SC, Tejiokem MC, Ekali GL, et al. Characteristics of patients co-infected with HIV at the time of inpatient tuberculosis treatment initiation in Yaoundé, Cameroon: a tertiary care hospital-based cross-sectional study. Archives of Public Health. 2015;73(1):24.
24. Musa BM, Musa B, Muhammed H, Ibrahim N, Musa AG. Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria. Ann Thorac Med. 2015;10(3):185–92.
25. Weldegebreal F, Mitiku H, Teklemariam Z. Treatment outcome of tuberculosis among Human Immunodeficiency Virus positive patients in Eastern Ethiopia: a retrospective study. Pan Afr Med J. 2018;30:32. doi: 10.11604/pamj.2018.30.32.12554.
26. Danlami MB, Basiru A, Tajjudeen Y, Bazata AY, Gulumbe BH, Mohammed M. Tuberculosis treatment outcomes among pulmonary TB patients attending public hospitals in Kebbi State, Northern Nigeria: a four-year retrospective study. Bull Natl Res Cent2022;46(1):281. doi: 10.1186/s42269-022-00969-9.
27. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998 Mar 25;279(12):943-8. doi: 10.1001/jama.279.12.943. Erratum in: JAMA 1998 Jul 8;280(2):134.
28. Selimin DS, Ismail A, Ahmad N, Ismail R, Mohd Azman NF, Azman A. Tuberculosis Treatment Outcome in Patients with TB-HIV Coinfection in Kuala Lumpur, Malaysia. J Trop Med 2021;2021:9923378. doi: 10.1155/2021/9923378.
29. Oshi D, Chukwu J, Nwafor C, Chukwu NE, Meka AO, Anyim M, et al. Support and unmet needs of patients undergoing multidrug-resistant tuberculosis (MDR-TB) treatment in southern Nigeria. Int J Health Plann Manage. 2020;35(4):832–42.
30. Eshetie S, Gizachew M, Alebel A, van Soolingen D. Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis. PLoS One. 2018;13(3):e0194675.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.
Ikechukwu kelechukwu Chukwuocha, Federal University Teaching Hospital Owerri
Department of Internal Medicine
Senior Registrar
Simon Mafuka Johnson
Department of Internal Medicine
Consultant physician
Ezinne Pamela Aguoru, Federal University Teaching Hospital Owerri
Department of internal Medicine
Senior Registrar